Paloma Partners’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-26,952
Closed -$3.56M 2095
2018
Q4
$3.56M Buy
+26,952
New +$3.45M 0.11% 145
2018
Q2
Sell
-11,023
Closed -$1.58M 2444
2018
Q1
$1.58M Buy
11,023
+2,066
+23% +$282K 0.02% 714
2017
Q4
$1.19M Buy
8,957
+2,118
+31% +$271K 0.02% 945
2017
Q3
$850K Sell
6,839
-1,070
-14% -$147K 0.01% 1238
2017
Q2
$1.11M Buy
+7,909
New +$988K 0.01% 1140
2017
Q1
Sell
-8,381
Closed -$977K 2376
2016
Q4
$881K Buy
+8,381
New +$901K 0.01% 1238
2016
Q1
Sell
-2,533
Closed -$408K 2175
2015
Q4
$408K Sell
2,533
-35,067
-93% -$5.42M 0.01% 1159
2015
Q3
$5.01M Buy
37,600
+34,800
+1,243% +$4.54M 0.12% 110
2015
Q2
$321K Buy
+2,800
New +$335K 0.01% 1292
2015
Q1
Sell
-10,100
Closed -$1.47M 1533
2014
Q4
$1.47M Sell
10,100
-4,718
-32% -$592K 0.06% 322
2014
Q3
$1.95M Sell
14,818
-78,355
-84% -$10.3M 0.09% 224
2014
Q2
$11.7M Buy
+93,173
New +$12M 0.48% 36

Paloma Partners's ATHN Position: Q1 2019 in Review

Paloma Partners sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 26,952 shares — an estimated $3.56M sold.

Paloma Partners first reported a position in ATHN in Q2 2014 and held it in 12 quarters. The position peaked at $11.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Paloma Partners reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Paloma Partners sold 26,952 Athenahealth, Inc. shares in Q1 2019, an estimated $3.56M.
  • Paloma Partners first reported a position in Athenahealth, Inc. in Q2 2014 and held it in 12 quarters.
  • Paloma Partners's Athenahealth, Inc. position peaked at $11.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.